Liaoning Oxiranchem (300082) Fundamentals 2026 — P/E 420.0x, Revenue Analysis | SniperIQ
Liaoning Oxiranchem (300082) is a CN-listed Basic Materials company in Chemicals - Specialty with a market capitalization of ¥4.6B, trading at ¥6.72 on the SHZ. This SniperIQ fundamentals page covers Liaoning Oxiranchem's valuation (P/E 420.0x, P/B 1.7x), profitability (net margin 0.3%), revenue (¥4.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Liaoning Oxiranchem's market cap?
Liaoning Oxiranchem (300082) has a market capitalization of approximately ¥4.6B, trading at ¥6.72 on the SHZ. Market cap moves with the live share price.
What is Liaoning Oxiranchem's P/E ratio?
Liaoning Oxiranchem's trailing twelve-month P/E ratio is 420.0x, with a price-to-book (P/B) of 1.7x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Liaoning Oxiranchem?
Liaoning Oxiranchem runs a net profit margin of 0.3%, a gross margin of 4.9%, and an operating margin of 1.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Liaoning Oxiranchem generate?
Liaoning Oxiranchem reported revenue of ¥4.2B for fiscal year 2025, with net income of ¥7M and earnings per share (EPS) of 0.01. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Liaoning Oxiranchem pay a dividend?
Liaoning Oxiranchem does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Liaoning Oxiranchem financially healthy?
Liaoning Oxiranchem carries a debt-to-equity ratio of 0.73x and a current ratio of 0.95x, with a market beta of 0.29. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Liaoning Oxiranchem a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Liaoning Oxiranchem (300082) the key facts are: market cap ¥4.6B, P/E 420.0x, revenue ¥4.2B, 52-week range 6.38-14.38. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Liaoning Oxiranchem's full fundamentals live
Get Liaoning Oxiranchem's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.